Innospec Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.8B-0.2% YoYTTM through 30 Jun 2026
Net Income $121.1M+240.2% YoYTTM through 30 Jun 2026
Free Cash Flow $87.9MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 27.7% |
| EBITDA Margin | 9.3% |
| Operating Margin | 7.3% |
| Net Margin | 6.6% |
Returns
8.7%ROE
6.4%ROA
11.1%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio2.78x
Net Debt-$292.5Mnet cash position
Cash & Equivalents$250.2M
Quality Metrics
Altman Z-Score5.39
Piotroski F-Score5 / 9
FCF Margin4.8%
Rule of 408.1
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $1.8B
Diluted EPS$4.90TTMFY2025: $4.67
Dividend
$0.92Per share, FY20260.96%Yield-4.5%5-yr growth
Capital Allocation
R&D Spend$52.1M
Capex Intensity2.0%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Performance Chemicals | $681.4M | +4.0% | View detailsFocused on delivering sustainable margin improvement through price/cost management, productivity, and new product commercialization. |
| Fuel Specialties | $701.5M | 0.0% | View detailsExpected to continue delivering consistent results and stable market demand. |
| Oilfield Services | $395.1M | -19.0% | View detailsPrioritizing margin and operating income improvement following reduced completion activity in the US and Middle East. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.